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Background: Eotaxin proteins are a potential therapeutic target in treating the peribronchial eosinophilia
associated with allergic airway diseases. Since inflammation is often associated with an increased generation of
reactive oxygen species (ROS), oxidative stress is a mechanistically imperative factor in asthma. Astragalin
(kaempferol-3-O-glucoside) is a flavonoid with anti-inflammatory activity and newly found in persimmon leaves and
green tea seeds. This study elucidated that astragalin inhibited endotoxin-induced oxidative stress leading to
eosinophilia and epithelial apoptosis in airways.
Methods: Airway epithelial BEAS-2B cells were exposed to lipopolysaccharide (LPS) in the absence and presence of
1–20 μM astragalin. Western blot and immunocytochemical analyses were conducted to determine induction of
target proteins. Cell and nuclear staining was also performed for ROS production and epithelial apoptosis.
Results: When airway epithelial cells were exposed to 2 μg/ml LPS, astragalin nontoxic at ≤20 μM suppressed
cellular induction of Toll-like receptor 4 (TLR4) and ROS production enhanced by LPS. Both LPS and H2O2 induced
epithelial eotaxin-1 expression, which was blocked by astragalin. LPS activated and induced PLCγ1, PKCβ2, and
NADPH oxidase subunits of p22phox and p47phox in epithelial cells and such activation and induction were demoted
by astragalin or TLR4 inhibition antagonizing eotaxin-1 induction. H2O2-upregulated phosphorylation of JNK and p38
MAPK was dampened by adding astragalin to epithelial cells, while this compound enhanced epithelial activation of Akt
and ERK. H2O2 and LPS promoted epithelial apoptosis concomitant with nuclear condensation or caspase-3 activation,
which was blunted by astragalin.
Conclusions: Astragalin ameliorated oxidative stress-associated epithelial eosinophilia and apoptosis through
disturbing TLR4-PKCβ2-NADPH oxidase-responsive signaling. Therefore, astragalin may be a potent agent
antagonizing endotoxin-induced oxidative stress leading to airway dysfunction and inflammation.
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Bronchial epithelium is a key regulator of airway inflam-
mation, airway wall remodeling and bronchial hyperre-
sponsiveness in asthma, a complex immunologic and
inflammatory disease [1]. There are secretion of cyto-
kines and activation of inflammatory cells, including
mast cells, T cells, eosinophils, and neutrophils [2-5].* Correspondence: yhkang@hallym.ac.kr
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reproduction in any medium, provided the orThere has been much circumstantial evidence implicating
eosinophil infiltration into airway epithelium as one of
major orchestrators in the pathophysiology of airway disor-
ders [5]. The development of eosinophilic infiltration into
the bronchial mucosa usually results in bronchial epi-
thelial damage and airways hyperresponsiveness [6,7].
Accordingly, the bronchial epithelium is a target of in-
flammatory and physical insults as well as an effecter of
ongoing airway inflammation. Accordingly, eosinophilic
inflammation might be associated with the pathophysi-
ology of acute exacerbations of airway diseases. Defining. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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into the airway epithelium can propose potential targets for
novel therapy. The eosinophil recruitment in experimental
airway diseases entails the binding of eotaxin to C-C che-
mokine receptor type 3 expressed on eosinophils, basophils
and Th2 cells [8].
Reactive oxygen species (ROS) can have detrimental ef-
fects on airway cells and tissues and hence oxidative stress
contributes to the initiation and deterioration of inflam-
matory airway disorders such as asthma [9,10]. Several
asthmatic mediators including chemokines and eosinophil
granule proteins are potential stimuli of ROS production
[11]. Some environmental factors linked to airway disor-
ders such as air pollutants may also cause an extreme
increase of ROS generation in the airway. In addition to
inflammatory cells recruited to the asthmatic airway, con-
stitutive airway cells such as epithelial cells are potential
resources of ROS [12]. Numerous studies reported that
the loss of antioxidant defenses was observed in airway
disorders [13,14]. Accordingly, the modification of airway
oxidative status may affect the pathological feature of air-
way disorders. It makes one take into account the neces-
sity of antioxidants therapies [10,15].
Astragalin (kaempferol-3-O-glucoside), a newly found
flavonoid from leaves of persimmon and green tea seeds,
and its heptaacetate are known to have anti-tumor, anti-
inflammatory and antioxidant activity [16,17]. Astragalin
can improve survival during lethal endotoxemia by
lipopolysaccharide (LPS) and attenuate inflammatory re-
sponses in a murine model of LPS-induced acute lung
injury [18]. Additionally, this compound inhibits derma-
titis development and IgE elevation in models of passive
cutaneous anaphylaxis and atopic dermatitis NC/Nga mice
[19]. However, the inhibitory effects of astragalin on asth-
matic responses such as eotaxin-1 induction and epithelial
apoptosis are not yet studied. Our recent study has dem-
onstrated that kaempferol attenuates eosinophil infiltra-
tion and airway inflammation in allergic asthma through
disturbing nuclear factor (NF)-κB signaling [20]. Another
flavonoid fisetin with similar chemical structure exerts
anti-asthma activity associated with reduction of Th2
responses and signaling suppression of NF-κB and down-
stream chemokines [21].
The cell membrane Toll-like receptor (TLR)4 recogniz-
ing LPS promotes inflammatory mechanisms including
NF-κB [22]. The TLR4 activation activates eotaxin-1 pro-
tein necessary for the eosinophil recruitment to the inflam-
matory lesions [20]. It is deemed that TLR4 can trigger the
crosstalk between eotaxin-1 induction and oxidative stress
via redox-dependent mechanism (s). Based on the litera-
ture evidence that astragalin possesses antioxidant property
and anti-allergic activity [18,19], this study investigated
whether astragalin inhibited eotaxin-1 induction and apop-
tosis of airway epithelial BEAS-2B cells due to LPS-induced oxidative stress. Furthermore, this study elucidated
whether astragalin encumbered airway eosinophilia and
epithelial apoptosis through disturbing TLR4-NADPH
oxidase pathway responsive to LPS.
Methods
Chemicals
M199, human epidermal growth factor (EGF), hydrocor-
tisone, gelatin, human insulin, apotransferrin, LPS and
H2O2 were obtained from the Sigma-Aldrich Chemical
(St. Louis, MO), as were all other reagents, unless specific-
ally stated elsewhere. Fetal bovine serum (FBS), penicillin-
streptomycin and trypsin-EDTA were purchased from
the Lonza (Walkersville, MD). The human bronchial
airway epithelial cell line BEAS-2B cells were provided
by the American Type Culture Collection (Manassas, VA).
3-(4, 5-Dimetylthiazol-yl)-diphenyl tetrazolium bromide
(MTT) was obtained from Duchefa Biochemie (Haarlem,
Netherlands). Human eotaxin-1 (CCL11) antibody was
purchased from R&D systems (Minneapolis, MN) and
human β-actin antibody obtained from Sigma-Aldrich
Chemicals. Antibodies against human TLR4, human
p22phox and human p47phox were purchased from the
Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies
against human phospho-PKC(pan)β2 (Ser660), human
PLCγ1, human phospho-ERK (p44/42 MAPK, Thr202/
Tyr204), human phospho-Akt, human phospho-SAPK/JNK
(Thr183/Tyr185), human phospho-p38 MAPK (Thr180/
Tyr182) and human cleaved caspase-3 were provided by
Cell Signaling Technology (Beverly, MA). Horseradish
peroxidase-conjugated goat anti-rabbit IgG, donkey anti-
goat IgG and goat anti-mouse IgG were purchased from
Jackson ImmunoResearch Laboratories (West Grove, PA).
4',6-Diamidino-2-phenylindole (DAPI) and 2′-7′-dichloro-
dihydrofluorescein diacetate (DCF-DA) was obtained from
Santa Cruz Biotechnology.
Astragalin was dissolved in dimethyl sulfoxide (DMSO)
for live culture with cells; a final culture concentration of
DMSO was ≤0.5%. The present study was approved by the
Hallym University Institutional Review Board and Com-
mittee on Animal Experimentation (hallym R2014-6).
BEAS-2B cell culture and viability
The human lung bronchus epithelial BEAS-2B cells
were cultured in 25 mM HEPES-buffered M199 con-
taining 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin,
100 μg/ml streptomycin supplemented with 2.5 μg/ml in-
sulin, 361 ng/ml hydrocortisone, 2.5 μg/ml apo-transferrin
and 20 ng/ml EGF. BEAS-2B cells were sustained in 90-
95% confluence at 37°C in an atmosphere of 5% CO2. LPS
at the concentration of 2 μg/ml was applied to BEAS-2B
cells for up to 8 h to induce target gene protein expression
and ROS production [20]. In another set of experiments,
cells were pretreated for 30 min with 1–20 μM astragalin
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treated cells were also incubated under the same condi-
tions as those used for the H2O2 protocols. Cells were
washed and resupplied with a fresh medium containing
1–20 μM astragalin.
The cytotoxicity of astragailn or H2O2 was deter-
mined using MTT assay after culture of BEAS-2B cells.
BEAS-2B cells were incubated in a fresh medium
containing 1 mg/ml MTT for 3 h at 37°C. The purple
formazan product was dissolved in 0.5 ml isopropanol
with gentle shaking. Absorbance of formed formazan
was measured at λ = 570 nm using a microplate reader
(Bio-Rad Model 550, Hercules, CA). In the current
study astragalin per se did not induce toxicity of BEAS-
2B cells at 1–20 μM (Figure 1B).Figure 1 Chemical structure of astragalin (A) and viability of BEAS-2B
measured by MTT assay and viability data are mean ± SEM (n = 5, cell viabi
TLR4 expression in LPS-exposed BEAS-2B cells (C and D). BEAS-2B cells wer
astragalin for 8 h. Cell lysates were prepared for Western blotting with a prima
control. The bar graphs (means ± SEM, n = 3) represent quantitative results of
the TLR4 induction were obtained by binding with a Cy3-conjugated IgG
formation, cells were incubated with 10 μM DCF-DA. At the end of DCF-D
measured (E). Fluorescent images (F) were obtained with a fluorescence micr
n = 3) not sharing a common superscript refer to significant different at P < 0.Western blot analysis
Whole BEAS-2B cell lysates were prepared in 1 mM
Tris–HCl (pH 6.8) lysis buffer containing 10% SDS, 1%
glycerophosphate, 0.1 mM Na3VO4, 0.5 mM NaF and pro-
tease inhibitor cocktail. Each cell lysate containing equal
amounts of proteins was electrophoresed on 8-15% SDS-
PAGE and transferred onto a nitrocellulose membrane.
Blocking a non-specific binding was performed using
either 3% fatty acid-free bovine serum albumin or 5%
non-fat dry milk for 3 h. The membrane was incubated
overnight at 4°C with a specific primary antibody of TLR4,
eotaxin-1, PLCγ1, phospho-PKCβ2, NADPH oxidases,
phosphorylated MAPK of JNK, p38, ERK and Akt or
cleaved caspase-3. The membrane was then applied to a
secondary antibody of goat anti-rabbit IgG or goat anti-cells treated with 1–20 μM astragalin for 24 h (B). Cell viability was
lity of untreated controls = 100%). Inhibitory effects of astragalin on
e cultured with 2 μg/ml LPS in the absence and presence of 1–20 μM
ry antibody against TLR4 (C). β-Actin protein was used as an internal
the upper bands obtained from a densitometer. Fluorescent images for
and by counterstaining with DAPI (D). For the measurement of ROS
A incubation, cells were lysed with NaOH and fluorescence was
oscopy. Image magnification: x200. Means in bar graphs (mean ± SEM,
05.
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Following another triple washing, each target protein level
was determined using the Supersignal West Pico Chemi-
luminescence detection reagents (Pierce Biotechnology,
Rockford, IL) and the Agfa medical X-ray film blue
(Agfa HealthCare NV, Mortsel, Belgium). Incubation with
mouse anti-human β-actin was conducted for the com-
parative control.Immunocytochemical analysis
Immunofluorescent cytochemical staining for monolayer
cells of BEAS-2B cells grown on glass coverslips was per-
formed using human TLR4 antibody and Cy3-conjugated
anti-rabbit IgG. BEAS-2B cells were fixed with 4% formal-
dehyde for 15 min and permeated with 0.1% Triton X-100
for 2 min on ice. Cells were blocked using a 4% FBS for
1 h, and anti-human TLR4 was applied to cells. Triple
washing was followed and incubation with Cy3-conjugated
goat anti-rabbit IgG was achieved for 1 h. Nuclear staining
was carried out with 4 mg/ml DAPI. Each slide was
mounted in VectaMount mounting medium (Vector
Laboratories, Burlingame, CA). Images of each slide were
taken using an optical microscope system (Axiomager,
Zeiss, Oberkochen, Germany). The TLR4 protein level was
quantified with an image analysis program from the micro-
scope system.Intracellular oxidant generation
Intracellular ROS production was detected by loading
DCF-DA hydrolyzed and oxidized by ROS to a fluorescent
compound DCF. BEAS-2B cells were treated with 2 μg/ml
LPS in the presence of 1–20 μM astragalin for 8 h, and
were incubated in DCF-DA for 30 min. After twice washes
with phosphate buffered saline (PBS), BEAS-2B cells were
lysed in 0.1 M NaOH. The equal amounts of cell lysates
were transferred to 96-black well plates and the fluores-
cence was measured at λ = 485 nm excitation and λ =
538 nm emission. After we completed dye loading at 37°C,
the cells were rinsed twice with PBS, and the cultures were
photographed with a fluorescence microscope.Nuclear staining
After treating 1–20 μM astragalin and 20 μM H2O2 to
BEAS-2B cells grown on a glass-chamber slide, a brief
washing with PBS-0.2% Tween 20 was conducted. BEAS-
2B cells were fixed with 4% formaldehyde for 15 min.
After blocking cells with a 4% FBS for 1 h, cells were
stained with 4 mg/ml DAPI to visualize nuclear condensa-
tion and fragmentation under fluorescence microscopy.
Images of each slide were taken using an optical micro-
scope system (Axiomager).Statistical analysis
The results were expressed as mean ± SEM in each
experiment. Statistical analyses were performed using
Statistical Analysis Systems statistical software package
(SAS Institute, Cary, NC). Significance was determined
by one-way analysis of variance, followed by Duncan
range test for multiple comparisons. Differences were
considered significant at P < 0.05.
Results
Suppression of LPS-promoted TLR4 induction by
astragalin
The TLR4 expression was very weak in untreated quies-
cent cells, whereas the TLR4 induction was greatly ele-
vated in 2 μg/ml LPS-exposed BEAS-2B cells (Figure 1C).
When epithelial cells were supplemented with ≥10 μM
astragalin for 8 h, the TLR4 induction was significantly
inhibited. Furthermore, the immunocytochemical ana-
lysis examined the localization of cellular TLR4 in
LPS-stimulated BEAS-2B cells, evaluated by fluores-
cent microscopy using a specific TLR4 antibody. There
was lack of cell membrane staining in the untreated
cells (Figure 1D). However, in LPS-stimulated BEAS-
2B cells for 8 h heavy pinkish staining was observed outside
blue colored-nuclei. The pinkish staining for the TLR4 in-
duction was substantially and dose-dependently diminished
in cells supplemented with astragalin (Figure 1D).
Astragalin inhibition of eotaxin-1 induction by
oxidative stress
We determined that in LPS-exposed cells astragalin in-
fluenced intracellular oxidant formation, as evidenced by
oxidation of DCF-DA. It was found that LPS highly ac-
celerated ROS production by 3.5-fold from BEAS-2B
cells (Figure 1E). The enhanced ROS production was
dose-dependently suppressed by supplementing astraga-
lin to epithelial cells. Figure 1F shows the expected weak
staining in the LPS-free control. The LPS-alone-exposed
cells showed heavy fluorescence, indicative of marked oxi-
dant generation. The cells exposed to LPS in the presence
of 20 μg/ml OxPAPC, a TLR2/4 signaling inhibitor [23],
revealed no increase in DCF fluorescence, indicating that
astragalin blocked an accumulation of intracellular oxi-
dants in epithelial cells due to LPS through disturbing
TLR signaling (Figure 1F).
This study investigated whether oxidative stress was
involved in the induction of eotaxin-1 protein in LPS-
experienced airway epithelial cells, which was inhibited by
treating astragalin. Eotaxin-1 expression was markedly
elevated in LPS-elicited BEAS-2B cells (Figure 2A). In
contrast, astragalin nontoxic at 1–20 μM attenuated the
eotaxin-1 induction in a dose-dependent manner. These
observation data imply that LPS-induced oxidants appeared
to be responsible for eotaxin-1 induction. Similarly, 20 μM
Figure 2 Inhibition of eotaxin-1 expression by astragalin in
LPS- or H2O2-exposed BEAS-2B cells. After BEAS-2B cell culture
protocols with 2 μg/ml LPS for 8 h (A) and or 20 μM H2O2 for 24 h
(B), cell lysates were prepared for Western blotting with anti-eotaxin-1.
β-Actin protein was used as an internal control. The bar graphs (mean ±
SEM, n = 3-4) represent quantitative results of the upper bands obtained
from a densitometer. Means not sharing a common superscript refer to
significant different at P< 0.05.
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cells, which was reversed by treating 1–20 μM astragalin
(Figure 2B). Accordingly, oxidative stress may be involved
in LPS-induction of airway epithelial eotaxin-1.Blockade of PLCγ1-PKCβ2-NADPH oxidase pathway
by astragalin
This study elucidated whether LPS induced cellular
signal transduction of PLCγ1-PKCβ2-NADPH oxidases
through stimulating TLR4 signaling, which was dis-
turbed by astragalin. The stimulation of epithelial cells
by LPS highly activated PLCγ1 in a temporal manner
with its peak expression at 4 h (Figure 3A). Adding
astragalin to LPS-exposed BEAS-2B cells significantly
inhibited the activation of PLCγ1, relative to that of
LPS-alone-exposed cells (Figure 3B). Additionally, astraga-
lin suppressed the phosphorylation of PKCβ2 elicited by
stimulating airway epithelial BEAS-2B cells with 2 μg/ml
LPS (Figure 3C). It was also found that LPS significantly
enhanced cellular expression of p22phox and p47phox and
astragalin encumbered such increased expression in a
dose-dependent manner (Figure 3D). This indicates that
astragalin ameliorated LPS-mediated eotaxin-1 via dis-
turbing PLCγ1-PKCβ2-NADPH oxidase signaling.
This study attempted to confirm that the TLR4 stimula-
tion elicited by LPS was linked to the eotaxin-1 induction
and the PLCγ1-NADPH oxidase signaling. The LPS-up-
regulated PKCβ2 activation was dampened by non-toxic
OxPAPC at 20 μg/ml (Figure 4). Similar inhibition was ob-
served with 20 μM astragalin. In addition, cellular expres-
sion of p22phox and p47phox up-regulated by LPS was
abolished by the TLR4 blockade of BEAS-2B cells, as with
eotaxin-1 induction by 2 μg/ml LPS (Figure 4). Conse-
quently, it was deemed that the ROS production by LPS
via its activation of TLR4-PKCβ2-NADPH oxidase signal-
ing induced bronchial eoaxin-1, which was deterred by
treating astragalin to epithelial cells.Inhibitory effect of astragalin on ROS-triggered apoptosis
and MAPK activation
LPS produced ROS in epithelial BEAS-2B cells through
stimulating TLR4-NADPH oxidase signaling (Figure 1E
and Figure 4). When BEAS-2B cells were incubated with
the ROS buster H2O2 at 20 μM, the phosphorylation of
p38 MAPK and JNK was highly enhanced (Figure 5A).
However, the activation of p38 MAPK and JNK was
dose-dependently suppressed in H2O2-exposed BEAS-2B
cells in the presence of ≥1 μM astragalin (Figure 5A).
Furthermore, this study examined the activation of other
MAPK proteins of ERK and Akt possibly involved in the
airway tissue damage. H2O2 per se minimally but signifi-
cantly up-regulated epithelial phosphorylation of ERK
and Akt (Figure 5B). When astragalin was supplemented
to H2O2-exposed BEAS-2B cells, the activation of ERK
and Akt was further dose-dependently enhanced. Ac-
cordingly, the ROS producer LPS like H2O2 affected
MAPK signaling pathway(s) of p38 and ERK in epithelial
cells (Figure 5C).
Figure 3 Time course response of PLCγ1 induction (A) and astragalin suppression of LPS-induced expression or activation of PLCγ1
(B), PKCβ2 (C), NADPH oxidases (D) by astragalin in BEAS-2B cells. Cells were treated with 1–20 μM astragalin and then stimulated with
2 μg/ml LPS for 8 h. Cell lysates were prepared for Western blot analysis with a primary antibody against PLCγ1, phospho-PKCβ2, p22phox, and
p47phox. β-Actin protein was used as an internal control. The bar graphs (mean ± SEM, n = 3-5) represent quantitative results of the upper bands
obtained from a densitometer Means not sharing a common superscript refer to significant different at P < 0.05.
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by loss of the normal bronchial pseudostratified epithe-
lium [24]. It was elucidated that MAPK signaling path-
way(s) was responsible for oxidative stress-associated
airway epithelial damage. H2O2 elicited nuclear conden-
sation and fragmentation of BEAS-2B cells, evidenced
by DAPI staining (Figure 6A). In contrast, astragalin
inhibited such nuclear changes, indicating that astragalin
can also dampen epithelial apoptosis by oxidative stress
triggered by LPS. Consistently, the apoptotic caspase-3
was activated in LPS-experienced epithelial cells, which
was attenuated by astragalin (Figure 6B). This finding
demonstrates that astragalin inhibited LPS-elicited air-
way epithelial apoptosis through disturbing the ROS
activation of p38 MAPK and promoting the activation
of ERK (Figure 5C). Finally, 20 μM astragalin increased
the viability of H2O2-exposed BEAS-2B cells by ≈ 15%
(Figure 6C). Also, astragalin appeared to demote the
susceptibility to apoptosis of LPS-exposed bronchial
epithelial cells (Figure 6D).
Discussion and conclusion
Six major findings were extracted from this study. 1)
When airway epithelial cells were exposed to 2 μg/ml
LPS, bronchial epithelial cell TLR4 was markedlyinduced. This induction was dose-dependently attenu-
ated by astragalin at 1–20 μM. 2) There was a marked
increase in ROS production of epithelial cells by LPS,
which was suppressed by adding astragalin. 3) Both the
oxidant H2O2 and LPS increased cellular expression of
eotaxin-1 of airway epithelial BEAS-2B cells. Such in-
duction was significantly suppressed by the treatment of
epithelial cells with astragalin non-toxic at ≤20 μM. 4)
Astragalin blunted the LPS activation and induction of
PLCγ1, PKCβ2 and NADPH oxidase subunits of p22phox
and p47phox through disturbing TLR4 signaling pertain-
ing to epithelial induction of eotaxin-1. 5) H2O2 pro-
moted epithelial apoptosis concomitant with rapid
phosphorylation of JNK and p38, which was reversed by
astragalin. In contrast, the activation of Akt and ERK
was up-regulated due to the presence of astragalin. 6)
LPS activated caspase-3 in epithelial cells, indicating
that LPS induced epithelial apoptosis. Astragalin deterred
such apoptosis and enhanced epithelial cell survival. There-
fore, astragalin can be effective in ameliorating asthmatic
airway diseases through modulating oxidative stress-
responsive signaling pathway linked to LPS-TLR4 sig-
naling. It cannot be ruled out that there may be a direct
binding of LPS to astragalin in triggering LPS-TLR4
signaling.
Figure 4 Suppression of LPS induction of NADPH oxidases by TLR4 blockade in BEAS-2B cells. Cells were treated with 20 μM astragalin
or 20 μg/ml OxPAPC and then stimulated with 2 μg/ml LPS for 8 h. Cell lysates were prepared for Western blot analysis with a primary
antibody against phospho-PKCβ2, p22phox, p47phox, and eotaxin-1. β-Actin protein was used as an internal control. The bar graphs (mean ± SEM,
n = 3-4) represent quantitative results of the upper bands obtained from a densitometer. Means not sharing a common superscript refer to
significant different at P < 0.05.
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Figure 5 Effects of astragalin on H2O2 (A and B)- or LPS (C)-induced activation of MAPK in BEAS-2B cells. Cells were exposed to 20 μM
H2O2 for 24 h or 2 μg/ml LPS for 8 h in the absence and presence of 1–20 μM astragalin. Cell lysates were prepared for Western blot analysis
with a primary antibody against phospho-ERK, phospho-Akt, phospho-p38, and phospho-JNK. β-Actin protein was used as an internal control. The
bar graphs (mean ± SEM, n = 3-4) represent quantitative results of the upper bands obtained from a densitometer. Means not sharing a common
superscript refer to significant different at P < 0.05.
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in the episode of asthma and results in airway epithelial
damage and hyperresponsiveness [5-7]. Eosinophils release
highly- cytotoxic granular proteins eliciting detrimental
tissue damage and severe inflammation [25]. Accord-
ingly, the blockade of eotaxin-1-induced eosinophil re-
cruitment may provide a novel therapeutic strategy for
airway disorders. Soy isoflavone dramatically inhibits
ovalbumin-induced eosinophil infiltration of lung tis-
sues and mucus production in a murine model of
asthma [26]. Soy isoflavone may be a novel means for
the treatment of airway inflammatory disease. Astraga-
lin found in persimmon leaves and green tea seeds, and
its heptaacetate have various bioactive actions including
anti-tumor, anti-inflammatory and antioxidant activities
[16,17]. This study revealed that astragalin suppressed
the eotaxin-1 induction possibly linked to TLR4 signal-
ing by LPS. Accordingly, this compound may block
eotaxin-1-associated eosinophilia in endotoxin-induced
airway disorders. Other investigation has shown that
astragalin inhibits dermatitis development and IgE
elevation in models of passive cutaneous anaphylaxis
and atopic dermatitis NC/Nga mice [19]. However, the
mechanism (s) by which the inhibitory effects of astra-
galin on asthmatic responses such as eotaxin-1 induc-
tion are not yet defined. The present study showed thatthe eotaxin-1 induction by LPS was linked to oxidative
stress due to ROS production and that astragalin sup-
pressed oxidant-induced eotaxin-1 expression with a
concurrent reduction of ROS production. One can as-
sume that this inhibitory effect of astragalin was at-
tributed to its scavenging activity of ROS or its direct
binding between astragalin and H2O2. The antioxi-
dant flavonoid naringenin attenuates mucous hyper-
secretion through modulating ROS production in
human airway epithelial cells [27]. In addition, tea
epigallocatechin-3-gallate diminished ROS generation
in bronchoalveolar lavage fluid by toluene diisocyanate
inhalation and protected airway inflammation in a mur-
ine model of asthma [28]. This study did not examine
the inhibition of ROS generation by astragalin in a mur-
ine asthma model. Nevertheless, it can be assumed that
the antioxidant astragalin can suppress in vivo airway
disorders.
Inflammatory cells recruited to the asthmatic airway
have an exceptional capability for producing ROS [29].
Mediators secreted in the asthmatic airway are potential
stimuli of ROS production [11]. Also, the constitutive
airway cells such as epithelial cells are potential re-
sources of ROS [12]. Activated inflammatory cells such
as eosinophils, neutrophils, monocytes, and macro-
phages can generate superoxides via the NADPH
Figure 6 Improvement of nuclear condensation and fragmentation (A), inhibition of caspase-3 activation (B) and enhancement of cell
viability (C and D) by astragalin in H2O2 -exposed or LPS-exposed BEAS-2B cells. Cells were exposed to 20 μM H2O2 for 24 h or 2 μg/ml
LPS for 8 h in the absence and presence of 1–20 μM astragalin, and DAPI staining or MTT assay was subsequently performed. Nuclear
condensation and fragmentation were observed with fluorescence microscopy. Representative microphotographs were obtained from three
independent experiments. The MTT data for viability are mean ± SEM (n = 5, cell viability of untreated controls = 100%). Cell lysates were prepared
for Western blot analysis with a primary antibody against cleaved caspase-3. β-Actin protein was used as an internal control. The bar graphs
(mean ± SEM, n = 3-4) represent quantitative results of the upper bands obtained from a densitometer. Means not sharing a common superscript
refer to significant different at P < 0.05.
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highly enhanced cellular expression of NADPH oxidase
subunits of p22phox and p47phox, which was blunted by
astragalin concomitantly with the dose-dependent in-
hibition of PKCβ2 activation. It was also shown that the
cell membrane-associated TLR4 signaling triggered the
crosstalk between eotaxin-1 induction and oxidative
stress via modulating redox-dependent mechanism (s).
Accordingly, astragalin appeared to suppress oxidant-
induced airway eosinophilia through disturbing TLR4-
PKCβ2-NADPH oxidase signaling responsive to LPS in
the airway epithelial cell system. Naringenin minimizes
ROS production-associated mucous production during
airway inflammation by inhibiting NF-κB activity via
EGF receptor-phosphatidylinositol 3-kinase-Akt/ERK
signaling pathway [27]. Some reports show that in-
creased oxidative stress and decreased levels of antioxi-
dants were observed in asthma [13,14]. However, the
endogenous antioxidant ability limits the extent of
cellular injury from oxidants during allergic insults.Airway epithelial cells are easily susceptible to in-
haled noxious agents and relatively refractory to apop-
totic stimuli. It has been reported that epithelial
apoptosis of the chronically inflamed airway can be
highly increased [30]. Survival mechanism (s) need in
place to maintain the integrity of the epithelial barrier
that is exposed to agents such as ROS and death recep-
tor ligands secreted by immune cells during inflamma-
tion. Thus, there is a necessity to develop strategies to
minimize ongoing damages to the airway epithelium
and consequent airway remodeling. Targeting major
apoptosis-manipulating factors in the inflamed airway
epithelium would be one of such strategies. This study
showed that the oxidant H2O2 promoted epithelial
apoptosis by up-regulating NADPH oxidases respon-
sible for the activation of JNK and p38 MAPK, which was
blocked by astragalin. One can think that the specific
inhibition of JNK and p38 MAPK signaling would be
necessary for their involvement in epithelial apoptosis.
The survival mechanisms by which astragalin inhibited
Figure 7 Schematic diagram showing anti-eosinophilic and anti-apoptotic features of astragalin and its mechanistic actions in
endotoxin-induced airway disorders. As depicted, astragalin inhibits the direct asthmatic signaling cascades induced by LPS. Arrows indicate
activation or induction; ⊥ indicates inhibition or blockade.
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activation of ERK signaling. The methoxyflavonoid
nobiletin inhibits eosinophilic airway inflammation by
promoting eosinophil apoptosis by enhancing Fas tran-
scription in asthmatic rats [31]. Natural polyphenols
hold promise as anti-asthmatic agents capable of influ-
encing multiple signaling pathways and immune cell
functions [32].
In summary, this study investigated the potential of
astragalin as a target antagonizing endotoxin- or oxida-
tive stress-associated airway eosinophilia and epithelial
apoptosis. Nontoxic astragalin suppressed LPS-induced
ROS production and eotaxin-1 expression in epithelial cells.
The LPS induction of eotaxin-1 was linked to oxidative
stress through triggering the signaling pathway of TLR4-
PKCγ1-PKCβ2-NADPH oxidases disturbed by astragalin.
Additionally, astragalin attenuated endotoxin-instigated
epithelial apoptosis through manipulating oxidative
stress-elicited MAPK signaling in airway epithelial cells.
Therefore, astragalin might be effective in ameliorating
oxidative stress-associated epithelial eosinophilia and
apoptosis through disturbing TLR4-PKCβ2-NADPH
oxidase-responsive signaling in a cellular model of air-
way disorder (Figure 7). Although astragalin may serveas a modulator against asthma in vitro, its dietary
in vivo role as an anti-asthmatic agent remains unclear.
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